Can manipulation of a pelvic tumour influence the serum level of cancer antigen 125 and cancer-associated serum antigen?

Cancer antigen 125 (CA 125) and cancer-associated serum antigen (CASA) were measured in 24 women with pelvic masses before and after a gynaecological examination and ultrasonography. CA 125 decreased median 16% after manipulation (P < 0.0001) and CASA decreased median 8% (P = 0.0077). The decline...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiekegaard, O., Mogensen, O., Mogensen, B., Ahrons, S.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150372/
https://www.ncbi.nlm.nih.gov/pubmed/9667684
_version_ 1782144610312650752
author Kiekegaard, O.
Mogensen, O.
Mogensen, B.
Ahrons, S.
author_facet Kiekegaard, O.
Mogensen, O.
Mogensen, B.
Ahrons, S.
author_sort Kiekegaard, O.
collection PubMed
description Cancer antigen 125 (CA 125) and cancer-associated serum antigen (CASA) were measured in 24 women with pelvic masses before and after a gynaecological examination and ultrasonography. CA 125 decreased median 16% after manipulation (P < 0.0001) and CASA decreased median 8% (P = 0.0077). The decline was found in patients with benign tumours as well as in patients with malignant tumours.
format Text
id pubmed-2150372
institution National Center for Biotechnology Information
language English
publishDate 1998
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-21503722009-09-10 Can manipulation of a pelvic tumour influence the serum level of cancer antigen 125 and cancer-associated serum antigen? Kiekegaard, O. Mogensen, O. Mogensen, B. Ahrons, S. Br J Cancer Research Article Cancer antigen 125 (CA 125) and cancer-associated serum antigen (CASA) were measured in 24 women with pelvic masses before and after a gynaecological examination and ultrasonography. CA 125 decreased median 16% after manipulation (P < 0.0001) and CASA decreased median 8% (P = 0.0077). The decline was found in patients with benign tumours as well as in patients with malignant tumours. Nature Publishing Group 1998-06 /pmc/articles/PMC2150372/ /pubmed/9667684 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Kiekegaard, O.
Mogensen, O.
Mogensen, B.
Ahrons, S.
Can manipulation of a pelvic tumour influence the serum level of cancer antigen 125 and cancer-associated serum antigen?
title Can manipulation of a pelvic tumour influence the serum level of cancer antigen 125 and cancer-associated serum antigen?
title_full Can manipulation of a pelvic tumour influence the serum level of cancer antigen 125 and cancer-associated serum antigen?
title_fullStr Can manipulation of a pelvic tumour influence the serum level of cancer antigen 125 and cancer-associated serum antigen?
title_full_unstemmed Can manipulation of a pelvic tumour influence the serum level of cancer antigen 125 and cancer-associated serum antigen?
title_short Can manipulation of a pelvic tumour influence the serum level of cancer antigen 125 and cancer-associated serum antigen?
title_sort can manipulation of a pelvic tumour influence the serum level of cancer antigen 125 and cancer-associated serum antigen?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150372/
https://www.ncbi.nlm.nih.gov/pubmed/9667684
work_keys_str_mv AT kiekegaardo canmanipulationofapelvictumourinfluencetheserumlevelofcancerantigen125andcancerassociatedserumantigen
AT mogenseno canmanipulationofapelvictumourinfluencetheserumlevelofcancerantigen125andcancerassociatedserumantigen
AT mogensenb canmanipulationofapelvictumourinfluencetheserumlevelofcancerantigen125andcancerassociatedserumantigen
AT ahronss canmanipulationofapelvictumourinfluencetheserumlevelofcancerantigen125andcancerassociatedserumantigen

Ejemplares similares